Design Therapeutics Stock Price History
DSGN Stock | USD 5.97 0.18 2.93% |
If you're considering investing in Design Stock, it is important to understand the factors that can impact its price. As of today, the current price of Design Therapeutics stands at 5.97, as last reported on the 28th of November, with the highest price reaching 6.25 and the lowest price hitting 5.87 during the day. Design Therapeutics appears to be moderately volatile, given 3 months investment horizon. Design Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0921, which denotes the company had a 0.0921% return per unit of risk over the last 3 months. By reviewing Design Therapeutics' technical indicators, you can evaluate if the expected return of 0.53% is justified by implied risk. Please utilize Design Therapeutics' Downside Deviation of 5.81, coefficient of variation of 1245.94, and Mean Deviation of 3.98 to check if our risk estimates are consistent with your expectations.
At this time, Design Therapeutics' Stock Based Compensation is very stable compared to the past year. As of the 28th of November 2024, Sale Purchase Of Stock is likely to grow to about 307.3 K, while Total Stockholder Equity is likely to drop about 213.9 M. . At this time, Design Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 28th of November 2024, Price To Book Ratio is likely to grow to 0.56, while Price To Sales Ratio is likely to drop about 2.5 M. Design Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Design |
Sharpe Ratio = 0.0921
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | DSGN | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
5.7 actual daily | 50 50% of assets are less volatile |
Expected Return
0.53 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Design Therapeutics is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Design Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.339 | Enterprise Value Ebitda (0.84) | Price Sales 22.6 K | Shares Float 25.2 M | Wall Street Target Price 7 |
Design Therapeutics Stock Price History Chart
There are several ways to analyze Design Stock price data. The simplest method is using a basic Design candlestick price chart, which shows Design Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 13, 2024 | 7.5 |
Lowest Price | October 7, 2024 | 4.56 |
Design Therapeutics November 28, 2024 Stock Price Synopsis
Various analyses of Design Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Design Stock. It can be used to describe the percentage change in the price of Design Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Design Stock.Design Therapeutics Price Daily Balance Of Power | (0.47) | |
Design Therapeutics Price Rate Of Daily Change | 0.97 | |
Design Therapeutics Price Action Indicator | (0.18) |
Design Therapeutics November 28, 2024 Stock Price Analysis
Design Stock Price History Data
The price series of Design Therapeutics for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 has a statistical range of 2.94 with a coefficient of variation of 9.91. Under current investment horizon, the daily prices are spread out with arithmetic mean of 5.44. The median price for the last 90 days is 5.48.Open | High | Low | Close | Volume | ||
11/28/2024 | 6.07 | 6.25 | 5.87 | 5.97 | ||
11/27/2024 | 6.07 | 6.25 | 5.87 | 5.97 | 77,621 | |
11/26/2024 | 5.62 | 6.18 | 5.53 | 6.15 | 138,600 | |
11/25/2024 | 5.71 | 5.89 | 5.62 | 5.62 | 77,441 | |
11/22/2024 | 5.60 | 5.80 | 5.47 | 5.62 | 83,710 | |
11/21/2024 | 5.57 | 5.73 | 5.43 | 5.57 | 100,167 | |
11/20/2024 | 5.47 | 5.51 | 5.34 | 5.48 | 72,195 | |
11/19/2024 | 5.65 | 5.70 | 5.32 | 5.48 | 86,161 | |
11/18/2024 | 5.81 | 5.81 | 5.40 | 5.76 | 146,684 | |
11/15/2024 | 5.91 | 5.98 | 5.61 | 5.80 | 240,269 | |
11/14/2024 | 7.51 | 7.54 | 5.71 | 6.02 | 312,401 | |
11/13/2024 | 6.95 | 7.77 | 6.95 | 7.50 | 397,611 | |
11/12/2024 | 6.52 | 6.95 | 6.43 | 6.91 | 204,614 | |
11/11/2024 | 5.88 | 6.83 | 5.76 | 6.61 | 249,308 | |
11/08/2024 | 5.77 | 5.93 | 5.32 | 5.83 | 161,253 | |
11/07/2024 | 5.92 | 6.20 | 5.76 | 5.79 | 109,129 | |
11/06/2024 | 5.75 | 6.12 | 5.57 | 5.94 | 202,379 | |
11/05/2024 | 5.34 | 5.57 | 5.25 | 5.56 | 95,660 | |
11/04/2024 | 5.15 | 5.34 | 5.05 | 5.32 | 85,999 | |
11/01/2024 | 5.28 | 5.30 | 5.05 | 5.20 | 69,394 | |
10/31/2024 | 5.57 | 5.63 | 5.22 | 5.24 | 71,393 | |
10/30/2024 | 5.37 | 5.59 | 5.29 | 5.57 | 89,194 | |
10/29/2024 | 5.50 | 5.50 | 5.22 | 5.41 | 58,923 | |
10/28/2024 | 5.54 | 5.74 | 5.36 | 5.53 | 64,920 | |
10/25/2024 | 5.40 | 5.49 | 5.31 | 5.44 | 66,282 | |
10/24/2024 | 5.68 | 5.78 | 5.33 | 5.35 | 55,931 | |
10/23/2024 | 5.60 | 5.69 | 5.47 | 5.66 | 77,338 | |
10/22/2024 | 5.56 | 5.78 | 5.43 | 5.67 | 80,199 | |
10/21/2024 | 5.56 | 5.72 | 5.33 | 5.60 | 110,148 | |
10/18/2024 | 6.01 | 6.01 | 5.31 | 5.60 | 144,830 | |
10/17/2024 | 5.67 | 6.02 | 5.61 | 6.02 | 627,021 | |
10/16/2024 | 5.45 | 5.73 | 5.39 | 5.65 | 123,488 | |
10/15/2024 | 5.16 | 5.43 | 5.14 | 5.39 | 114,865 | |
10/14/2024 | 5.00 | 5.19 | 4.95 | 5.15 | 142,936 | |
10/11/2024 | 4.63 | 5.01 | 4.63 | 5.00 | 203,948 | |
10/10/2024 | 4.63 | 4.68 | 4.50 | 4.67 | 80,755 | |
10/09/2024 | 4.92 | 4.92 | 4.62 | 4.68 | 156,824 | |
10/08/2024 | 4.53 | 4.93 | 4.49 | 4.92 | 187,206 | |
10/07/2024 | 5.00 | 5.01 | 4.49 | 4.56 | 137,770 | |
10/04/2024 | 4.79 | 5.02 | 4.70 | 5.00 | 200,998 | |
10/03/2024 | 4.96 | 4.96 | 4.51 | 4.72 | 240,682 | |
10/02/2024 | 5.15 | 5.16 | 4.66 | 4.97 | 385,304 | |
10/01/2024 | 5.36 | 5.36 | 5.00 | 5.15 | 273,586 | |
09/30/2024 | 5.32 | 5.44 | 5.25 | 5.38 | 112,423 | |
09/27/2024 | 5.49 | 5.62 | 5.30 | 5.33 | 135,951 | |
09/26/2024 | 5.49 | 5.54 | 5.34 | 5.42 | 85,399 | |
09/25/2024 | 5.41 | 5.50 | 5.31 | 5.38 | 102,157 | |
09/24/2024 | 5.38 | 5.46 | 5.21 | 5.41 | 164,564 | |
09/23/2024 | 5.92 | 5.92 | 5.35 | 5.35 | 195,454 | |
09/20/2024 | 5.82 | 6.13 | 5.77 | 5.88 | 639,321 | |
09/19/2024 | 5.79 | 5.95 | 5.71 | 5.86 | 156,793 | |
09/18/2024 | 5.75 | 5.87 | 5.56 | 5.64 | 196,341 | |
09/17/2024 | 5.62 | 5.96 | 5.55 | 5.77 | 285,080 | |
09/16/2024 | 5.57 | 5.86 | 5.44 | 5.55 | 173,713 | |
09/13/2024 | 5.85 | 5.97 | 5.20 | 5.54 | 291,282 | |
09/12/2024 | 5.36 | 6.01 | 5.35 | 5.84 | 376,987 | |
09/11/2024 | 5.65 | 5.79 | 5.05 | 5.22 | 465,133 | |
09/10/2024 | 5.10 | 6.91 | 4.98 | 5.64 | 4,506,059 | |
09/09/2024 | 4.58 | 4.97 | 4.58 | 4.88 | 162,029 | |
09/06/2024 | 4.72 | 4.79 | 4.50 | 4.67 | 97,175 | |
09/05/2024 | 4.85 | 4.85 | 4.60 | 4.71 | 87,949 |
About Design Therapeutics Stock history
Design Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Design is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Design Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Design Therapeutics stock prices may prove useful in developing a viable investing in Design Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 56 M | 46.6 M | |
Net Loss | -57 M | -54.1 M |
Design Therapeutics Quarterly Net Working Capital |
|
Design Therapeutics Stock Technical Analysis
Design Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
All Next | Launch Module |
Design Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Design Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Design Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Design to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0701 | |||
Jensen Alpha | 0.1562 | |||
Total Risk Alpha | (0.40) | |||
Sortino Ratio | 0.0557 | |||
Treynor Ratio | 0.179 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Design Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Design Stock, please use our How to Invest in Design Therapeutics guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Design Therapeutics. If investors know Design will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Design Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.85) | Revenue Per Share 0.001 | Return On Assets (0.14) | Return On Equity (0.18) |
The market value of Design Therapeutics is measured differently than its book value, which is the value of Design that is recorded on the company's balance sheet. Investors also form their own opinion of Design Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Design Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Design Therapeutics' market value can be influenced by many factors that don't directly affect Design Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Design Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Design Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Design Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.